Mersana Therapeutics Statistics
Total Valuation
MRSN has a market cap or net worth of $65.87 million. The enterprise value is -$57.78 million.
Important Dates
The next estimated earnings date is Friday, March 7, 2025, before market open.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRSN has 123.53 million shares outstanding. The number of shares has increased by 9.52% in one year.
| Current Share Class | 123.53M |
| Shares Outstanding | 123.53M |
| Shares Change (YoY) | +9.52% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 50.44% |
| Float | 78.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.86 |
| Forward PS | 3.10 |
| PB Ratio | 62.46 |
| P/TBV Ratio | 62.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 30.05.
| Current Ratio | 2.35 |
| Quick Ratio | 2.29 |
| Debt / Equity | 30.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.77 |
Financial Efficiency
Return on equity (ROE) is -280.29% and return on invested capital (ROIC) is -83.33%.
| Return on Equity (ROE) | -280.29% |
| Return on Assets (ROA) | -22.97% |
| Return on Invested Capital (ROIC) | -83.33% |
| Return on Capital Employed (ROCE) | -78.49% |
| Revenue Per Employee | $283,228 |
| Profits Per Employee | -$606,659 |
| Employee Count | 123 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRSN has paid $418,000 in taxes.
| Income Tax | 418,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.31% in the last 52 weeks. The beta is 1.38, so MRSN's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -85.31% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 32.83 |
| Average Volume (20 Days) | 5,414,211 |
Short Selling Information
The latest short interest is 9.47 million, so 7.66% of the outstanding shares have been sold short.
| Short Interest | 9.47M |
| Short Previous Month | 9.95M |
| Short % of Shares Out | 7.66% |
| Short % of Float | 12.01% |
| Short Ratio (days to cover) | 1.02 |
Income Statement
In the last 12 months, MRSN had revenue of $34.84 million and -$74.62 million in losses. Loss per share was -$0.61.
| Revenue | 34.84M |
| Gross Profit | -37.39M |
| Operating Income | -79.45M |
| Pretax Income | -134.81M |
| Net Income | -74.62M |
| EBITDA | -77.78M |
| EBIT | -79.45M |
| Loss Per Share | -$0.61 |
Full Income StatementBalance Sheet
The company has $155.17 million in cash and $31.53 million in debt, giving a net cash position of $123.65 million or $1.00 per share.
| Cash & Cash Equivalents | 155.17M |
| Total Debt | 31.53M |
| Net Cash | 123.65M |
| Net Cash Per Share | $1.00 |
| Equity (Book Value) | 1.05M |
| Book Value Per Share | 0.01 |
| Working Capital | 92.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$95.05 million and capital expenditures -$518,000, giving a free cash flow of -$95.57 million.
| Operating Cash Flow | -95.05M |
| Capital Expenditures | -518,000 |
| Free Cash Flow | -95.57M |
| FCF Per Share | -$0.77 |
Full Cash Flow StatementMargins
Gross margin is -107.33%, with operating and profit margins of -228.07% and -214.19%.
| Gross Margin | -107.33% |
| Operating Margin | -228.07% |
| Pretax Margin | -212.99% |
| Profit Margin | -214.19% |
| EBITDA Margin | -223.26% |
| EBIT Margin | -228.07% |
| FCF Margin | n/a |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.52% |
| Shareholder Yield | -9.52% |
| Earnings Yield | -113.29% |
| FCF Yield | -145.09% |
Analyst Forecast
The average price target for MRSN is $6.00, which is 1,025.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 1,025.28% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 45.80% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MRSN has an Altman Z-Score of -6.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.87 |
| Piotroski F-Score | 3 |